Global Preclinical CRO Treatment Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Preclinical CRO Treatment Revenue
• 1.4 Market by Type
  • 1.4.1 Global Preclinical CRO Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Bioanalysis and DMPK Studies
  • 1.4.3 Toxicology Testing
  • 1.4.4 Others
• 1.5 Market by Application
  • 1.5.1 Global Preclinical CRO Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Biopharmaceutical Companies
  • 1.5.3 Government and Academic Institutes
  • 1.5.4 Medical Device Companies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Preclinical CRO Treatment Market Perspective (2015-2026)
• 2.2 Global Preclinical CRO Treatment Growth Trends by Regions
  • 2.2.1 Preclinical CRO Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Preclinical CRO Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Preclinical CRO Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Preclinical CRO Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Preclinical CRO Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Preclinical CRO Treatment Players by Market Size
  • 3.1.1 Global Top Preclinical CRO Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Preclinical CRO Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Preclinical CRO Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Preclinical CRO Treatment Market Concentration Ratio
  • 3.2.1 Global Preclinical CRO Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Preclinical CRO Treatment Revenue in 2019
• 3.3 Preclinical CRO Treatment Key Players Head office and Area Served
• 3.4 Key Players Preclinical CRO Treatment Product Solution and Service
• 3.5 Date of Enter into Preclinical CRO Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Preclinical CRO Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Preclinical CRO Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Preclinical CRO Treatment Market Size by Application (2015-2020)
• 5.2 Global Preclinical CRO Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Preclinical CRO Treatment Market Size (2015-2020)
• 6.2 Preclinical CRO Treatment Key Players in North America (2019-2020)
• 6.3 North America Preclinical CRO Treatment Market Size by Type (2015-2020)
• 6.4 North America Preclinical CRO Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Preclinical CRO Treatment Market Size (2015-2020)
• 7.2 Preclinical CRO Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Preclinical CRO Treatment Market Size by Type (2015-2020)
• 7.4 Europe Preclinical CRO Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Preclinical CRO Treatment Market Size (2015-2020)
• 8.2 Preclinical CRO Treatment Key Players in China (2019-2020)
• 8.3 China Preclinical CRO Treatment Market Size by Type (2015-2020)
• 8.4 China Preclinical CRO Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Preclinical CRO Treatment Market Size (2015-2020)
• 9.2 Preclinical CRO Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Preclinical CRO Treatment Market Size by Type (2015-2020)
• 9.4 Japan Preclinical CRO Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Preclinical CRO Treatment Market Size (2015-2020)
• 10.2 Preclinical CRO Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Preclinical CRO Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Preclinical CRO Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Preclinical CRO Treatment Market Size (2015-2020)
• 11.2 Preclinical CRO Treatment Key Players in India (2019-2020)
• 11.3 India Preclinical CRO Treatment Market Size by Type (2015-2020)
• 11.4 India Preclinical CRO Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Preclinical CRO Treatment Market Size (2015-2020)
• 12.2 Preclinical CRO Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Preclinical CRO Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Preclinical CRO Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Charles River Laboratories
  • 13.1.1 Charles River Laboratories Company Details
  • 13.1.2 Charles River Laboratories Business Overview
  • 13.1.3 Charles River Laboratories Preclinical CRO Treatment Introduction
  • 13.1.4 Charles River Laboratories Revenue in Preclinical CRO Treatment Business (2015-2020))
  • 13.1.5 Charles River Laboratories Recent Development
• 13.2 Laboratory Corporation of America
  • 13.2.1 Laboratory Corporation of America Company Details
  • 13.2.2 Laboratory Corporation of America Business Overview
  • 13.2.3 Laboratory Corporation of America Preclinical CRO Treatment Introduction
  • 13.2.4 Laboratory Corporation of America Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.2.5 Laboratory Corporation of America Recent Development
• 13.3 Envigo
  • 13.3.1 Envigo Company Details
  • 13.3.2 Envigo Business Overview
  • 13.3.3 Envigo Preclinical CRO Treatment Introduction
  • 13.3.4 Envigo Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.3.5 Envigo Recent Development
• 13.4 Eurofins Scientific
  • 13.4.1 Eurofins Scientific Company Details
  • 13.4.2 Eurofins Scientific Business Overview
  • 13.4.3 Eurofins Scientific Preclinical CRO Treatment Introduction
  • 13.4.4 Eurofins Scientific Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.4.5 Eurofins Scientific Recent Development
• 13.5 PRA Health Science
  • 13.5.1 PRA Health Science Company Details
  • 13.5.2 PRA Health Science Business Overview
  • 13.5.3 PRA Health Science Preclinical CRO Treatment Introduction
  • 13.5.4 PRA Health Science Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.5.5 PRA Health Science Recent Development
• 13.6 Wuxi AppTec
  • 13.6.1 Wuxi AppTec Company Details
  • 13.6.2 Wuxi AppTec Business Overview
  • 13.6.3 Wuxi AppTec Preclinical CRO Treatment Introduction
  • 13.6.4 Wuxi AppTec Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.6.5 Wuxi AppTec Recent Development
• 13.7 Medpace
  • 13.7.1 Medpace Company Details
  • 13.7.2 Medpace Business Overview
  • 13.7.3 Medpace Preclinical CRO Treatment Introduction
  • 13.7.4 Medpace Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.7.5 Medpace Recent Development
• 13.8 Pharmaceutical Product Development
  • 13.8.1 Pharmaceutical Product Development Company Details
  • 13.8.2 Pharmaceutical Product Development Business Overview
  • 13.8.3 Pharmaceutical Product Development Preclinical CRO Treatment Introduction
  • 13.8.4 Pharmaceutical Product Development Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.8.5 Pharmaceutical Product Development Recent Development
• 13.9 Paraxel
  • 13.9.1 Paraxel Company Details
  • 13.9.2 Paraxel Business Overview
  • 13.9.3 Paraxel Preclinical CRO Treatment Introduction
  • 13.9.4 Paraxel Revenue in Preclinical CRO Treatment Business (2015-2020)
  • 13.9.5 Paraxel Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer